These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

237 related items for PubMed ID: 6160907

  • 21. Antagonistic effects of systemic interleukin 2 on immune Tcell-mediated graft-versus-leukemia reactivity.
    Schirrmacher V, Müerköster S, Umansky V.
    Clin Cancer Res; 1998 Nov; 4(11):2635-45. PubMed ID: 9829726
    [Abstract] [Full Text] [Related]

  • 22. Suppressor macrophages in tumor-bearing mice and their selective inhibition by 6-mercaptopurine.
    Kataoka T, Oh-hashi F.
    Cancer Res; 1985 May; 45(5):2139-44. PubMed ID: 3157443
    [Abstract] [Full Text] [Related]

  • 23. Effector mechanism of tumor immunity in murine plasmacytoma.
    Chen YH, Anderson AB.
    Cancer Res; 1988 Mar 15; 48(6):1398-403. PubMed ID: 3257896
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Use of adoptive transfer and Winn assay procedures in the further analysis of antiviral acquired immunity in mice protected against Friend leukemia virus-induced disease by passive serum therapy.
    Genovesi EV, Pettey CL, Collins JJ.
    Cancer Res; 1984 Apr 15; 44(4):1489-98. PubMed ID: 6608407
    [Abstract] [Full Text] [Related]

  • 27. [The role of immune RNA in the immunotherapy of malignant brain tumor (author's transl)].
    Nakamura O, Takakura K.
    No To Shinkei; 1982 Apr 15; 34(4):333-9. PubMed ID: 6178420
    [Abstract] [Full Text] [Related]

  • 28. Cell-mediated immune responses to syngeneic ultraviolet-induced tumours. V. Assessment of accessory and antigen-presenting cell capabilities of normal and ultraviolet-irradiated mice in the generation of anti-tumour cytotoxic effector cells in vitro.
    Lynch DH, Gurish MF, Daynes RA.
    Immunology; 1982 Sep 15; 47(1):49-59. PubMed ID: 6981587
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Macrophage tumoricidal activity as a possible antitumor mechanism associated with the local injection of allogeneic spleen cells into rats.
    Kawase I, Komuta K, Namba M, Yokota S, Ogura T, Kishimoto S.
    Cancer Res; 1986 Mar 15; 46(3):1047-54. PubMed ID: 3510719
    [Abstract] [Full Text] [Related]

  • 33. Chemotherapy and immunotherapy of L1210 leukemic mice with antigenic tumor sublines.
    Nicolin A, Canti G, Marelli O, Veronese F, Goldin A.
    Cancer Res; 1981 Apr 15; 41(4):1358-62. PubMed ID: 7011535
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Suppressor T cell circuits in contact sensitivity. I. Two mechanistically distinct waves of suppressor T cells occur in mice tolerized with syngeneic DNP-modified lymphoid cells.
    Miller SD, Butler LD, Claman HN.
    J Immunol; 1982 Aug 15; 129(2):461-8. PubMed ID: 6211486
    [Abstract] [Full Text] [Related]

  • 36. Tumor-specific suppressor cells induced by immunization with spleen cells from tumor-bearing animals.
    Huber SA, Bigi G, Lucas ZJ.
    Cancer Res; 1980 Oct 15; 40(10):3477-83. PubMed ID: 6449281
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. [Suppressor mechanism in tumor immunology: characteristics of suppressor T-cells in glioma-bearing mice].
    Yamasaki T, Yamashita J, Handa H, Namba Y, Hanaoka M.
    No To Shinkei; 1983 Jul 15; 35(7):703-9. PubMed ID: 6194806
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.